parkinson glutathione oxidative ipsc crispr Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease Stem cells strike back: advancements
Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024 PMC Frontiers Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy CRISPR And iPSC Disease Modeling And Drug Screening CRISPR Cas9 assisted stem cell therapy in Parkinson's disease Biomaterials Research
Pay in 4 interest-free payments of $6.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21



